| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 STAMBPL1 USP17L22 USP17L15 USP17L8 USP17L13 | 1.05e-23 | 124 | 115 | 20 | GO:0101005 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.66e-23 | 114 | 115 | 19 | GO:0004843 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 STAMBPL1 USP17L22 USP17L15 USP17L8 USP17L13 | 8.57e-23 | 137 | 115 | 20 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 ADGB USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 8.78e-20 | 192 | 115 | 20 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 IDE USP17L18 ADGB USP17L17 ADAMTS9 USP17L6P USP17L3 ERVK-19 STAMBPL1 ERVK-25 USP17L22 USP17L15 USP17L8 USP17L13 | 3.85e-14 | 654 | 115 | 25 | GO:0008233 |
| GeneOntologyMolecularFunction | aldehyde oxidase activity | 1.96e-04 | 4 | 115 | 2 | GO:0004031 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor | 3.25e-04 | 5 | 115 | 2 | GO:0016623 | |
| GeneOntologyMolecularFunction | chromatin insulator sequence binding | 6.78e-04 | 7 | 115 | 2 | GO:0043035 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 9.00e-04 | 8 | 115 | 2 | GO:0004571 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 STAMBPL1 USP17L22 USP17L15 USP17L8 USP17L13 | 6.63e-24 | 125 | 115 | 20 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 STAMBPL1 USP17L22 USP17L15 USP17L8 USP17L13 | 1.29e-22 | 144 | 115 | 20 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L21 USP17L4 OGT USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 SMC5 USP17L18 USP17L17 USP17L6P USP17L3 STAMBPL1 USP17L22 USP17L15 USP17L8 USP17L13 | 3.44e-08 | 1009 | 115 | 22 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L21 USP17L4 OGT USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 SMC5 USP17L18 USP17L17 USP17L6P USP17L3 STAMBPL1 USP17L22 USP17L15 USP17L8 USP17L13 | 1.03e-07 | 1074 | 115 | 22 | GO:0043687 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 USP17L21 USP17L4 FMO5 USP17L2 GALNT1 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 TYRO3 DST USP17L17 USP17L6P USP17L3 USP17L22 PLOD1 EIF2AK3 FKBP2 USP17L15 USP17L8 USP17L13 | 2.80e-08 | 1293 | 115 | 25 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 USP17L21 USP17L4 FMO5 USP17L2 GALNT1 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 TYRO3 DST USP17L17 USP17L6P USP17L3 USP17L22 PLOD1 EIF2AK3 FKBP2 USP17L15 USP17L8 USP17L13 | 3.07e-08 | 1299 | 115 | 25 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L21 USP17L4 FMO5 USP17L2 GALNT1 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 TYRO3 DST USP17L17 USP17L6P USP17L3 USP17L22 PLOD1 EIF2AK3 FKBP2 USP17L15 USP17L8 USP17L13 | 4.65e-08 | 1327 | 115 | 25 | GO:0042175 |
| MousePheno | increased trophectoderm apoptosis | 9.90e-06 | 8 | 80 | 3 | MP:0012119 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13 | 3.04e-30 | 16 | 110 | 14 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13 | 3.04e-30 | 16 | 110 | 14 | IPR006861 |
| Domain | UCH | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 2.71e-23 | 71 | 110 | 17 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 2.71e-23 | 71 | 110 | 17 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 3.53e-23 | 72 | 110 | 17 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 3.53e-23 | 72 | 110 | 17 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 3.53e-23 | 72 | 110 | 17 | IPR001394 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 4.52e-22 | 66 | 110 | 16 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.29e-21 | 70 | 110 | 16 | PS00972 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF536 ZNF219 ZNF555 ZNF366 ZNF423 ZNF207 HIC2 ZNF524 ZNF236 ZBTB7B ZFX CTCFL ZNF341 ZNF43 ZFP64 AEBP2 ZNF816 ZNF398 ZNF512 | 1.22e-07 | 775 | 110 | 19 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF536 ZNF219 ZNF555 ZNF366 ZNF423 ZNF207 HIC2 ZNF524 ZNF236 ZBTB7B ZFX CTCFL ZNF341 ZNF43 ZFP64 AEBP2 ZNF816 ZNF398 ZNF512 | 1.27e-07 | 777 | 110 | 19 | PS00028 |
| Domain | Znf_C2H2-like | ZNF536 ZNF219 ZNF555 ZNF366 ZNF423 ZNF207 HIC2 ZNF524 ZNF236 ZBTB7B ZFX CTCFL ZNF341 ZNF43 ZFP64 AEBP2 ZNF816 ZNF398 ZNF512 | 1.85e-07 | 796 | 110 | 19 | IPR015880 |
| Domain | Znf_C2H2 | ZNF536 ZNF219 ZNF555 ZNF366 ZNF423 ZNF207 HIC2 ZNF524 ZNF236 ZBTB7B ZFX CTCFL ZNF341 ZNF43 ZFP64 AEBP2 ZNF816 ZNF398 ZNF512 | 2.20e-07 | 805 | 110 | 19 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF536 ZNF219 ZNF555 ZNF366 ZNF423 ZNF207 HIC2 ZNF524 ZNF236 ZBTB7B ZFX CTCFL ZNF341 ZNF43 ZFP64 AEBP2 ZNF816 ZNF398 ZNF512 | 2.33e-07 | 808 | 110 | 19 | SM00355 |
| Domain | - | ZNF536 ZNF219 ZNF555 ZNF366 ZNF423 HIC2 ZNF524 ZNF236 ZBTB7B ZFX CTCFL ZNF341 ZNF43 ZFP64 AEBP2 ZNF816 ZNF398 | 4.57e-07 | 679 | 110 | 17 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF536 ZNF219 ZNF555 ZNF366 ZNF423 HIC2 ZNF524 ZNF236 ZBTB7B ZFX CTCFL ZNF341 ZNF43 ZFP64 ZNF816 ZNF398 ZNF512 | 6.06e-07 | 693 | 110 | 17 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF536 ZNF219 ZNF555 ZNF366 ZNF423 HIC2 ZNF524 ZNF236 ZBTB7B ZFX CTCFL ZNF341 ZNF43 ZFP64 AEBP2 ZNF816 ZNF398 | 6.19e-07 | 694 | 110 | 17 | IPR013087 |
| Domain | PBC | 2.05e-04 | 4 | 110 | 2 | PF03792 | |
| Domain | PBX | 2.05e-04 | 4 | 110 | 2 | IPR005542 | |
| Domain | zf-C2H2_6 | 5.42e-04 | 314 | 110 | 8 | PF13912 | |
| Domain | Glyco_hydro_47 | 7.08e-04 | 7 | 110 | 2 | PF01532 | |
| Domain | - | 7.08e-04 | 7 | 110 | 2 | 1.50.10.50 | |
| Domain | Glyco_hydro_47 | 9.40e-04 | 8 | 110 | 2 | IPR001382 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.90e-29 | 45 | 87 | 18 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 IDE USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.06e-18 | 191 | 87 | 19 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L4 OGT USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 IDE USP17L18 USP17L17 USP17L6P USP17L3 STAMBPL1 USP17L22 USP17L15 USP17L8 USP17L13 | 5.11e-18 | 262 | 87 | 21 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L4 OGT USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 IDE USP17L18 USP17L17 USP17L3 STAMBPL1 USP17L22 USP17L15 USP17L8 USP17L13 | 1.19e-15 | 299 | 87 | 20 | M27574 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 IDE USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.21e-15 | 221 | 87 | 18 | M27578 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 RASGRP3 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.27e-14 | 318 | 87 | 19 | MM15278 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 FBXO40 USP17L4 MAN1A1 OGT USP17L2 GALNT1 USP17L12 USP17L1 DPH7 USP17L20 COG7 FOLR2 USP17L11 USP17L24 WRN USP17L5 NUP214 USP17L19 IDE SMC5 USP17L18 MAN1A2 USP17L17 ADAMTS9 ST6GALNAC5 USP17L3 STAMBPL1 USP17L22 USP17L15 USP17L8 USP17L13 | 6.28e-11 | 1475 | 87 | 32 | M19806 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 USP17L21 FBXO40 USP17L4 MAN1A1 OGT USP17L2 GALNT1 USP17L12 USP17L1 USP17L20 COG7 FOLR2 USP17L11 USP17L5 NUP214 USP17L19 IDE SMC5 USP17L18 MAN1A2 USP17L17 ADAMTS9 ST6GALNAC5 USP17L6P USP17L3 STAMBPL1 USP17L22 USP17L15 USP17L8 USP17L13 | 6.93e-11 | 1389 | 87 | 31 | MM15307 |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI | 3.72e-04 | 5 | 87 | 2 | M27954 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI | 3.72e-04 | 5 | 87 | 2 | MM15670 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.27e-43 | 21 | 115 | 18 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.27e-43 | 21 | 115 | 18 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.27e-43 | 21 | 115 | 18 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.27e-43 | 21 | 115 | 18 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.27e-43 | 21 | 115 | 18 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.27e-43 | 21 | 115 | 18 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.99e-42 | 22 | 115 | 18 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.30e-41 | 24 | 115 | 18 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.60e-40 | 25 | 115 | 18 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 8.43e-40 | 26 | 115 | 18 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.21e-39 | 33 | 115 | 19 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 20403174 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 20388806 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 14699124 |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.74e-39 | 34 | 115 | 19 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.99e-39 | 35 | 115 | 19 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.99e-39 | 35 | 115 | 19 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.26e-38 | 36 | 115 | 19 | 20147298 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.85e-38 | 29 | 115 | 18 | 32527007 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.59e-38 | 37 | 115 | 19 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 PRAMEF13 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.31e-35 | 50 | 115 | 19 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 4.99e-19 | 10 | 115 | 8 | 24207026 |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 5.46e-18 | 12 | 115 | 8 | 24695638 | |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 3.29e-17 | 14 | 115 | 8 | 11793228 |
| Pubmed | USP17L7 CDK16 USP17L21 ZNF536 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 PRAMEF13 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 CATSPERG USP17L15 USP17L8 USP17L13 | 6.24e-16 | 674 | 115 | 22 | 37196079 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 8.18e-16 | 19 | 115 | 8 | 28067227 |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8 | 2.94e-10 | 81 | 115 | 8 | 12838346 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 NIPAL4 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17 | 6.45e-09 | 119 | 115 | 8 | 28625976 |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 1.41e-07 | 4 | 115 | 3 | 22984479 | |
| Pubmed | ZNF219 ZNF423 ASH1L PBX4 ZNF207 ZNF236 ZBTB7B ZNF43 ZFP64 AEBP2 PXN ZNF398 PBX3 ZNF512 | 4.87e-07 | 808 | 115 | 14 | 20412781 | |
| Pubmed | 5.53e-07 | 48 | 115 | 5 | 16421571 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP17L7 OGT ATXN7L2 USP17L2 MYO6 CNOT10 POLR1C WRN ZNF207 NUP214 WDR59 STRIP1 PRPF3 STAMBPL1 | 6.15e-06 | 1005 | 115 | 14 | 19615732 |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 32144534 | ||
| Pubmed | Bpag1 localization to actin filaments and to the nucleus is regulated by its N-terminus. | 1.08e-05 | 2 | 115 | 2 | 14576348 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 14621294 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 11971179 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 33592173 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDK16 OGT COG7 CNOT10 NUP214 IDE SMC5 NSUN2 STRIP1 TSR1 PRPF3 PLOD1 PLK4 DDX28 | 2.89e-05 | 1155 | 115 | 14 | 20360068 |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 10915796 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 8144579 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 9592125 | ||
| Pubmed | OGT CNOT10 DDX52 POLR1C WRN ZNF207 RICTOR ZBTB7B STRIP1 IFRD1 MAN1A2 DST TSR1 PXN MICU2 DDX28 | 3.45e-05 | 1497 | 115 | 16 | 31527615 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 9.06e-05 | 316 | 115 | 7 | 31665637 | |
| Pubmed | Pbx4, a new Pbx family member on mouse chromosome 8, is expressed during spermatogenesis. | 1.08e-04 | 5 | 115 | 2 | 11335119 | |
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 25701821 | ||
| Pubmed | Transcription factor PBX4 regulates limb development and haematopoiesis in mice. | 1.08e-04 | 5 | 115 | 2 | 38230761 | |
| Pubmed | 1.60e-04 | 153 | 115 | 5 | 10718198 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | USP17L7 USP17L12 PBX4 HIC2 KARS1 DST R3HCC1L ADAMTS9 PKHD1 USP17L3 | 1.72e-04 | 736 | 115 | 10 | 29676528 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ASH1L PBX4 HIC2 ZNF524 ZNF236 ZBTB7B ZFX CTCFL ZNF43 ZNF398 PBX3 | 2.18e-04 | 908 | 115 | 11 | 19274049 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 2.20e-04 | 759 | 115 | 10 | 35915203 | |
| Pubmed | 3.00e-04 | 8 | 115 | 2 | 17121831 | ||
| Pubmed | OGT MYO6 ZNF423 POLR1C ASH1L NSUN2 WDR59 MAN1A2 DST ADAMTS9 STAMBPL1 TBC1D23 PBX3 | 3.35e-04 | 1285 | 115 | 13 | 35914814 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF219 OGT ATXN7L2 DDX52 POLR1C WRN NUP214 ZBTB7B ZFX KARS1 DST PRPF3 ZFP64 | 3.58e-04 | 1294 | 115 | 13 | 30804502 |
| Pubmed | 3.84e-04 | 9 | 115 | 2 | 20927120 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 3.98e-04 | 670 | 115 | 9 | 22990118 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | OGT MYO6 ASH1L IDE ZNF236 ANKRD44 IFRD1 PRPF3 RIN2 ZFP64 PBX3 ZNF512 CATSPERG PLOD1 | 4.10e-04 | 1489 | 115 | 14 | 28611215 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO6 DDX52 POLR1C RICTOR NUP214 RRM2 NSUN2 WDR59 KARS1 DST PRPF3 ZNF512 PLOD1 | 5.45e-04 | 1353 | 115 | 13 | 29467282 |
| Pubmed | 5.85e-04 | 11 | 115 | 2 | 26952749 | ||
| Pubmed | Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblasts. | 5.85e-04 | 11 | 115 | 2 | 23630078 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.71e-04 | 440 | 115 | 7 | 34244565 | |
| Pubmed | 7.00e-04 | 12 | 115 | 2 | 37720106 | ||
| Pubmed | ILDR2 stabilization is regulated by its interaction with GRP78. | 7.00e-04 | 12 | 115 | 2 | 33863978 | |
| Pubmed | Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. | 7.00e-04 | 12 | 115 | 2 | 15467718 | |
| Pubmed | 7.26e-04 | 446 | 115 | 7 | 24255178 | ||
| Pubmed | 8.26e-04 | 13 | 115 | 2 | 16847320 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | OGT USP17L1 ZNF423 ZNF207 HIC2 KARS1 DST TSR1 PRPF3 CATSPERG PLOD1 | 9.40e-04 | 1082 | 115 | 11 | 38697112 |
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 1.05e-03 | 134 | 115 | 4 | 28695742 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.05e-03 | 134 | 115 | 4 | 25452129 | |
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 1.05e-03 | 60 | 115 | 3 | 29055695 | |
| Pubmed | 1.11e-03 | 15 | 115 | 2 | 30071041 | ||
| Pubmed | 1.11e-03 | 15 | 115 | 2 | 8892864 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MAN1A1 GALNT1 MYO6 DDX52 POLR1C NUP214 NSUN2 IFRD1 KARS1 PLOD1 | 1.17e-03 | 942 | 115 | 10 | 31073040 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.19e-03 | 486 | 115 | 7 | 30940648 | |
| Pubmed | Screening for replication of genome-wide SNP associations in sporadic ALS. | 1.26e-03 | 16 | 115 | 2 | 18987618 | |
| Pubmed | 1.43e-03 | 17 | 115 | 2 | 2355006 | ||
| Pubmed | 1.44e-03 | 146 | 115 | 4 | 29688375 | ||
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 1.44e-03 | 248 | 115 | 5 | 27926873 | |
| Pubmed | 1.51e-03 | 653 | 115 | 8 | 22586326 | ||
| Pubmed | 1.55e-03 | 149 | 115 | 4 | 25184681 | ||
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 1.59e-03 | 150 | 115 | 4 | 22678362 | |
| Pubmed | 1.60e-03 | 18 | 115 | 2 | 19838193 | ||
| Pubmed | 1.61e-03 | 660 | 115 | 8 | 32780723 | ||
| Pubmed | 1.78e-03 | 72 | 115 | 3 | 12107413 | ||
| Pubmed | 1.79e-03 | 19 | 115 | 2 | 20161779 | ||
| Pubmed | Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. | 1.79e-03 | 19 | 115 | 2 | 14578343 | |
| Pubmed | Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. | 1.79e-03 | 19 | 115 | 2 | 30385546 | |
| Pubmed | p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. | 1.79e-03 | 19 | 115 | 2 | 16105984 | |
| Pubmed | Proteomics characterization of abundant Golgi membrane proteins. | 1.79e-03 | 19 | 115 | 2 | 11042173 | |
| Pubmed | 1.79e-03 | 19 | 115 | 2 | 19139842 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.91e-03 | 678 | 115 | 8 | 30209976 | |
| Pubmed | 1.98e-03 | 20 | 115 | 2 | 19862325 | ||
| Pubmed | Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI. | 1.98e-03 | 20 | 115 | 2 | 19933996 | |
| Interaction | FLT3 interactions | USP17L21 NIPAL4 USP17L12 USP17L20 USP17L11 DDX52 USP17L19 NSUN2 USP17L18 KARS1 USP17L17 ZNF512 | 1.26e-07 | 318 | 107 | 12 | int:FLT3 |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.74e-20 | 79 | 115 | 13 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.76e-14 | 222 | 115 | 13 | chr4p16 |
| Cytoband | 8p23.1 | 2.69e-06 | 154 | 115 | 6 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 2.91e-05 | 234 | 115 | 6 | chr8p23 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF536 ZNF219 ZNF555 ZNF366 ZNF423 ZNF207 HIC2 ZNF524 ZNF236 ZBTB7B ZFX CTCFL ZNF341 ZNF43 ZFP64 ZNF816 ZNF398 ZNF512 | 1.26e-10 | 718 | 69 | 18 | 28 |
| GeneFamily | Mannosidases alpha class 1 | 8.57e-05 | 4 | 69 | 2 | 1193 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 6.48e-26 | 86 | 112 | 18 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.10e-23 | 112 | 112 | 18 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 IFRD1 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.44e-22 | 160 | 112 | 19 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 DPH7 USP17L20 USP17L11 USP17L5 USP17L19 CNBD2 USP17L18 GPR146 USP17L17 SLC20A1 RIN2 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.27e-15 | 647 | 112 | 23 | MM981 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L4 OGT USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 ASH1L USP17L5 USP17L19 WDR59 USP17L18 GPR146 USP17L17 DCLRE1C SLC20A1 USP17L6P USP17L3 DLEC1 USP17L22 USP17L15 USP17L8 USP17L13 | 3.00e-12 | 1072 | 112 | 25 | MM1031 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 CDK16 USP17L21 USP17L4 MAN1A1 FMO5 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 ABHD6 USP17L5 USP17L19 SMC5 USP17L18 USP17L17 ST6GALNAC5 USP17L6P USP17L3 USP17L22 USP17L15 DKK2 USP17L8 USP17L13 | 3.27e-11 | 1198 | 112 | 25 | MM1062 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L4 ZNF219 USP17L2 USP17L12 USP17L1 DPH7 USP17L20 USP17L11 USP17L5 USP17L19 CNBD2 USP17L18 GPR146 USP17L17 ZNF43 SLC20A1 RIN2 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.34e-11 | 1226 | 112 | 25 | MM979 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 4.87e-06 | 156 | 91 | 7 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_top-relative-expression-ranked_100 | 2.00e-05 | 77 | 91 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | 3.54e-05 | 378 | 91 | 9 | gudmap_developingLowerUrinaryTract_adult_bladder_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#4_top-relative-expression-ranked_500 | 3.76e-05 | 44 | 91 | 4 | gudmap_developingLowerUrinaryTract_adult_ureter_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#2_top-relative-expression-ranked_200 | 4.49e-05 | 46 | 91 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#2_top-relative-expression-ranked_100 | 7.02e-05 | 19 | 91 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_100_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_200 | 1.27e-04 | 23 | 91 | 3 | gudmap_developingGonad_e18.5_epididymis_200_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.83e-04 | 469 | 91 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 3.93e-06 | 175 | 106 | 6 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 4.92e-06 | 182 | 106 | 6 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 5.08e-06 | 183 | 106 | 6 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 5.08e-06 | 183 | 106 | 6 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.93e-06 | 188 | 106 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.69e-06 | 192 | 106 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | B_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.56e-05 | 164 | 106 | 5 | f45013706a917f0f0d69c23f288128f252cd60c7 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.69e-05 | 165 | 106 | 5 | 47e716ce8dc283d406352c1909e09362fcb9e3a3 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.69e-05 | 165 | 106 | 5 | fe2135fdacf3807eb4b5ea5e790febfb8cd54335 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.83e-05 | 166 | 106 | 5 | bb8135119dc37fdbba476599a56d368f422688dc | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-05 | 169 | 106 | 5 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 169 | 106 | 5 | bca5322880c09b78ef10d9dda6420a80c1ba7e62 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.20e-05 | 175 | 106 | 5 | d983e80eeb11f341c564ea684e2b0b585a90ae58 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.09e-05 | 180 | 106 | 5 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-05 | 180 | 106 | 5 | a600bc705993d3a010550a25d3b54358946f061f | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.86e-05 | 184 | 106 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.06e-05 | 185 | 106 | 5 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 8.27e-05 | 186 | 106 | 5 | a08a50bff4e629588faa22440d57334b1df0e8df | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.48e-05 | 187 | 106 | 5 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-05 | 187 | 106 | 5 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 187 | 106 | 5 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.48e-05 | 187 | 106 | 5 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 8.70e-05 | 188 | 106 | 5 | c7b1807c96f87fbcd37739a159cf00f9a1ff5d71 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.70e-05 | 188 | 106 | 5 | 5d166d9e71632edd059ff0a9f66f8763f259d40a | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.87e-05 | 98 | 106 | 4 | fca0baf13520c53edb6da2fe3eb152fbd44df5ed | |
| ToppCell | 390C-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.14e-05 | 190 | 106 | 5 | f63c9474f23bb72f0bb1fc531342f0da04ed8b3e | |
| ToppCell | 390C-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.14e-05 | 190 | 106 | 5 | 53bf211f0e8a44f5adb89c43b210a1e35120b6a8 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.60e-05 | 192 | 106 | 5 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.60e-05 | 192 | 106 | 5 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.84e-05 | 193 | 106 | 5 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.84e-05 | 193 | 106 | 5 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 196 | 106 | 5 | fd18a9ae8401121ae276adff1a85d5f938e2df91 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 197 | 106 | 5 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.08e-04 | 197 | 106 | 5 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 198 | 106 | 5 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 198 | 106 | 5 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 198 | 106 | 5 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | 1.14e-04 | 199 | 106 | 5 | c11aa8bca3723a886e7082ae48bb922dd8396be4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 106 | 5 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD16|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 106 | 5 | 94d7aa057a31287696a634d15ce91ce64af6455b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 106 | 5 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 106 | 5 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 106 | 5 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 106 | 5 | 4077a85ceb8bb423c06179e16fd870ab95f8a2e8 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.34e-35 | 46 | 110 | 19 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.56e-31 | 69 | 110 | 19 | DOID:1682 (implicated_via_orthology) |
| Disease | breast ductal carcinoma (is_marker_for) | 3.80e-04 | 8 | 110 | 2 | DOID:3007 (is_marker_for) | |
| Disease | Opioid use measurement | 1.40e-03 | 15 | 110 | 2 | EFO_0009937 | |
| Disease | cyclic adenosine monophosphate measurement | 1.81e-03 | 17 | 110 | 2 | EFO_0010473 | |
| Disease | interleukin 18 measurement | 2.91e-03 | 76 | 110 | 3 | EFO_0004581 | |
| Disease | unipolar depression, neuroticism measurement | 3.60e-03 | 24 | 110 | 2 | EFO_0003761, EFO_0007660 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 3.60e-03 | 24 | 110 | 2 | EFO_0009458, MONDO_0007079 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPSILMLHGFSAHKD | 71 | Q9BV23 | |
| RFTCKGKPVHHFMNT | 141 | P40394 | |
| KKLCYDQGISGHHLM | 831 | Q6ZRH7 | |
| CGAHRAPARKNHKKM | 206 | A0A494C0N9 | |
| HMIHKAAVAAKKFGP | 266 | Q9Y2R4 | |
| QRHMLTHSGDKPFKC | 316 | Q6ZN18 | |
| KEKHRCHMSCPHLSP | 1531 | Q9NR48 | |
| TAHFAKGLEMALLPH | 321 | P83436 | |
| PCAKKLEEIHMGHCV | 191 | Q8IY45 | |
| MKTHTSEKPHLCHLC | 276 | Q8NI51 | |
| EFLHSKGLMHRDLKP | 926 | Q9NZJ5 | |
| HIYSLCKAVKGHMPL | 176 | Q8N7X0 | |
| EKCEMKLHGPHKNLF | 1451 | Q12774 | |
| GLYQCIIHHKKPTGM | 106 | P42081 | |
| KMSHIKGHEGDPCLR | 171 | Q9UBU2 | |
| LIKEDMSIFGHCPAH | 61 | Q5T6C5 | |
| GILMHIKPENHCSKL | 596 | Q7Z5L2 | |
| DGSLSHPKEHMLCKE | 226 | Q8IXS6 | |
| PHHKILDMCAAPGSK | 176 | Q08J23 | |
| AKKHALNCHRMKPAL | 66 | P40426 | |
| IPKLHMLELHCESKC | 526 | O00533 | |
| KKMCLFHLTHLSDIG | 791 | Q9NPP4 | |
| HCPIKSRKGDVLHMH | 41 | P26885 | |
| KNDPCRVHHHGSKML | 7346 | Q03001 | |
| GIHIKNCRHFMPKIS | 111 | Q53TS8 | |
| SKLHCIMPHVKQTFL | 356 | Q9NUL7 | |
| MKFPIHHLALSCDNL | 91 | P35658 | |
| AKCGIHSMFPLHLAA | 366 | Q8N8A2 | |
| LSCHPHGVKMLEKCS | 666 | Q6R327 | |
| LFHHSKLDPDMAFCA | 471 | Q02809 | |
| KGKITFCMGIHVAHL | 566 | A2A3N6 | |
| CITAMAKKFHPEHFV | 546 | P49023 | |
| KHALNCHRMKPALFS | 41 | Q9BYU1 | |
| SKLNGPVTMLKCHHL | 486 | Q10472 | |
| PVTMLKCHHLKGNQL | 491 | Q10472 | |
| KLLKIFCAGMHSDHP | 1761 | Q9P2N4 | |
| LSHCHKDHMKGLRAP | 31 | Q96SD1 | |
| HLLLAACMHSGFKIL | 296 | Q9BTV6 | |
| MKHPFFLSLGERIHK | 441 | Q00536 | |
| DHEMFGLKPKHRALS | 266 | P49326 | |
| DHCGKMEPACKRHFI | 81 | P14207 | |
| MHFHKLPSLLSCDDV | 266 | O00458 | |
| GCPLSMSRHKLAKHL | 71 | Q9UH90 | |
| LLEHKMGHLTCFAGG | 466 | P33908 | |
| GHLEKKMGHLACFAG | 451 | O60476 | |
| LSHFCEHMLFLGTKK | 106 | P14735 | |
| KHTLSMLRCFHSKGV | 1451 | Q6ZMW3 | |
| MKKLPCGDRHCSPDH | 311 | Q96CH1 | |
| LTHLALPCHVSGMKK | 1046 | Q9Y238 | |
| LLHKLHLAKVGDCMG | 391 | Q8WUM9 | |
| CPTENMAREHFKKHG | 651 | O43395 | |
| MKTLGKLVFSRCHHS | 231 | Q5VWM6 | |
| GDHANMFPHLKKKAV | 706 | O15294 | |
| AAHMKTCLFHKTLHP | 211 | P51575 | |
| HMRSHLGLKPFACDE | 551 | Q96JB3 | |
| HIGGLPLNMSIKKCH | 226 | A5PLK6 | |
| HMLPHLHFGLKDKET | 211 | Q15046 | |
| AKSQLHCKMGPGFIH | 481 | Q8IV61 | |
| TKPHSGFHVAFKMLD | 171 | Q8IYU8 | |
| TKFCSGHAPHFPMKK | 271 | Q5VSL9 | |
| LGVADHKPLKMHCRD | 81 | Q9BVH7 | |
| HKPLKMHCRDCALVT | 86 | Q9BVH7 | |
| HPKLEAFISHMSKGS | 126 | Q8TE99 | |
| VMDLAKHLPHAFSKL | 261 | Q14191 | |
| SLLLGHFAHKGSLCM | 2441 | P08F94 | |
| HFAHKGSLCMSSGIK | 2446 | P08F94 | |
| LMHCVKGIGKDHAKF | 211 | O15160 | |
| LKMPHEKHYTLCGTP | 161 | O00444 | |
| PHPKLLHKGSCFGEM | 176 | Q96M20 | |
| KARKCLHQAASMIHP | 661 | Q9H9A5 | |
| SHVKKHLLSCFAVMG | 686 | P63136 | |
| AMKKACLPGHKQVDH | 171 | A6NCW0 | |
| HKCILKPLKGHVEAM | 596 | Q8WYP3 | |
| RPDKLKAHILSHSGM | 666 | Q9BYN7 | |
| IKEPLGTHGHMKCSF | 741 | Q2NL82 | |
| RHMISHTGEKPHKCK | 301 | Q8NEP9 | |
| CHKIIHGAGKLPRHM | 351 | O15156 | |
| AMKKACLPGHKQVDH | 171 | A6NCW7 | |
| DFACLMFKHLVHKPS | 271 | P31350 | |
| MLEVSACKKKGFHPH | 396 | Q96FJ0 | |
| CPHCGKSFIRKHHLM | 541 | Q8TD17 | |
| HLHLADDCMKHFKGS | 346 | Q15833 | |
| KHHFPCKEVKESGHM | 591 | Q9NUY8 | |
| CKEVKESGHMFPSHL | 596 | Q9NUY8 | |
| AMKKACLPGHKQVDH | 171 | D6R9N7 | |
| AMKKACLPGHKQVDH | 171 | A8MUK1 | |
| AMKKACLPGHKQVDH | 171 | D6R901 | |
| AMKKACLPGHKQVDH | 171 | C9JLJ4 | |
| KVIGDKFFIMHHCAS | 111 | Q96MV1 | |
| AMKKACLPGHKQVDH | 171 | D6RCP7 | |
| LAVPDKHHMCCGKEK | 211 | Q96LQ0 | |
| AMKKACLPGHKQVDH | 171 | Q7RTZ2 | |
| KDLDISCASLPHMHK | 346 | Q0D2K0 | |
| KSFCMLPHLAQHKII | 181 | P17038 | |
| HCSNHRVKMLVKFPA | 421 | Q6PJI9 | |
| SLHMRTHTGEKPFKC | 146 | O15090 | |
| AMKKACLPGHKQVDH | 171 | C9JPN9 | |
| HKKLYTGPGLAIHCM | 41 | O43670 | |
| CGKLFKQLSHLHTHM | 286 | Q8N895 | |
| AMKKACLPGHKQVDH | 171 | Q0WX57 | |
| MCDKGFHRPSELKKH | 666 | P17010 | |
| HMRLHTGAKPFKCPH | 1241 | Q9UL36 | |
| AMKKACLPGHKQLDH | 171 | P0C7H9 | |
| AMKKACLPGHKQVDH | 171 | P0C7I0 | |
| SHVKKHLLSCFAVMG | 691 | Q9WJR5 | |
| MFDSPAKLLCHLIEH | 1206 | Q2M1K9 | |
| HAKRKHPEAMGVPLC | 216 | Q96C55 | |
| AMKKACLPGHKQVDH | 171 | Q6QN14 | |
| AMKKACLPGHKQVDH | 171 | D6RA61 | |
| KSIGPPEMHKYHCEL | 201 | Q8IY18 | |
| AMKKACLPGHKQVDH | 171 | C9J2P7 | |
| AMKKACLPGHKQVDH | 171 | D6RBQ6 | |
| ELEKMTLKCHHCGKP | 281 | Q96ME7 | |
| RHMIVHSGEKPFKCE | 431 | Q9NTW7 | |
| CMKEFDHPHVAKLVG | 571 | Q06418 | |
| GHMRKHKASFDHACP | 291 | Q9P2Y4 | |
| AMKKACLPGHKQVDH | 171 | Q6R6M4 | |
| AMKKACLPGHKQVDH | 171 | D6RJB6 | |
| HHIGDFCFPEMKKDI | 96 | Q0VGE8 | |
| AMKKACLPGHKQVDH | 171 | C9JVI0 | |
| IRCIKPNLKMTSHHF | 666 | Q9UM54 |